Wall Street Hedge

Tuesday, March 2, 2021
Log in
  • Home
  • Nation & Politics
  • Financial News
  • Technology & Research
  • Lifestyle & Health
    • Latest News
      • Business
      • Nature
      • Science
      • World
      • VA Hospitals Are Still Under Investigation for Suspected Drug Thefts

Cubist Pharmaceuticals gets FDA nod for its experimental drug Zerbaxa

By Leave a Comment

BN-FX457_cubist_P_20141208091641

The US Food and Drug Administration (FDA) on Friday gave green signal to drug maker Cubist Pharmaceuticals for its experimental antibiotic Zerbaxa to treat complicated intra-abdominal infection (cIAI) and complicated urinary tract infection (cUTI).

This is the second antibiotic approval by the federal agency for the company this year.

The FDA gave its nod to the drug maker after two pivotal Phase III clinical studies showed positive results for its experimental antibiotics.

The trials involved 979 adults. In the first study, the researchers evaluated the efficacy of the drug against cUTI, while they tested the drug against cIAI in the second study.

Both cUTI and cIAI infections are caused by gram-negative bacteria called ‘superbugs’, a class of antibiotic-resistant pathogens.

According to the reports, Zerbaxa met the primary endpoints for two pre-specified medical trials that agreed upon with the federal body and the European Medicines Agency.

The company expects the green signal from EU during the second half of next year. Some of the common side-effects of the drug included diarrhea, nausea and headache.

With the development, Zerbaxa has become the fourth anti-bacterial drug to win FDA’s nod this year. The federal body has given it the status of a qualified infectious disease product (QIDP) under the Generating Antibiotic Incentives Now Act. The status has been awarded to the experimental drug as it belongs to the category of drugs for the treatment of severe forms of infections caused by the superbugs. It is also the fourth drug to be get the QIDP status.

 

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Lifestyle & Health Tagged With: cIAI, complicated intra-abdominal infection, complicated urinary tract infection, Cubist Pharmaceuticals, FDA, QIDP, qualified infectious disease product, US Food and Drug Administration, Zerbaxa

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Recent Articles

AXA building in Wiesbaden, Germany.

Insurer AXA To Buy XL Group For $15 Billion

By Leave a Comment

New York Stock Exchange on Wall Street.

Wall Street Comes Out Intact As Global Stock Rise

By Leave a Comment

Ryanair profits are up despite threats of pilot strike.

Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

By Leave a Comment

Bitcoin bubble may burst, analysts speculate.

Bitcoin Bubble Shows Signs Of Bursting

By Leave a Comment

One percent amassed 82 percent of the world's fortune last year.

82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

By Leave a Comment

Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

By Leave a Comment

General Electric Laboratory

High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

By Leave a Comment

Cryptocurrency bitcoin coins

Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

By Leave a Comment

Computer circuit board

Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

By Leave a Comment

Thanksgiving dinner

Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

By Leave a Comment

Doctors in surgery

Vermont Is Preparing New Health Care System

By Leave a Comment

Saudi Arabia’s capital city Riyadh

Saudi Arabia Has Just Bought Huge Stake in Uber

By Leave a Comment

No Agreement Yet on the Trans-Pacific Partnership

By Leave a Comment

Samsung Shareholders Approve Deal Which Sees Lee Family Gain More Control

By Leave a Comment

Related Articles

  • Shaving brush after being dipped into a bowl full of shaving foam

    Strange Sunburn Remedy Goes Viral and Doctors Confirm It Might Actually Work

  • Flight attendant serving coffee and water to the passengers

    Flight Attendants Have a More Elevated Cancer Risk than the Normal Population (Study)

  • Hand lying on the floor next to an empty pill bottle

    British Man Claims a Horror Video Game Caused His Son to Commit Suicide

  • Bud of a cannabis plant with hairy leaves

    FDA Has Approved the First Drug Produced from Cannabis, but It Can’t Go on the Market Yet

  • Colorful tattoo on a person's right leg

    Woman with Weak Immune System Develops Knee Pain After Getting a Leg Tattoo (Study)

  • Teenage girls talking next to a metal fence

    Teenagers Are Laying Off Risky Behaviors, But Don’t Take Good Care of their Health

  • Teaspoon full of sugar

    Toddlers Eat a Lot More Added Sugar than They Should

  • Man eating a cookie and spilling jam on his tie

    Why Do People Become Hangry? Researchers Offer Psychological Explanation (Study)

  • Teddy bear with a crumpled tissue, a vaccine container, and a syringe on it

    You Can Get $3,500 If You Leave Yourself Infected with the Flu at Hotel Influenza

  • Viagra pill placed on a white surface

    Man Sues CVS for Leaking Information on His Viagra Prescription to His Wife

Categories

  • Business
  • Entertainment
  • Financial News
  • Lifestyle & Health
  • Nation & Politics
  • National News
  • Nature
  • Science
  • Technology & Research
  • World

Copyright © 2021 WallStreetHedge.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.